Items related to Azapropazone: 20 years of clinical use
Azapropazone is a chemically unique non-steroidal anti-inflammatory drug (benzotriazine oxide) which has found successful clinical applications in the therapy of a wide variety of arthritic conditions. This book summarizes the progress and critically reviews the clinical use and experimental studies since its introduction 20 years ago. Several studies focus on the physiochemical, pharmacological and toxico logical properties of this drug. The studies suggest that it has some unique properties compared with other non-steroidal anti-inflammatory drugs. Among these the novel observations are that azapropazone inhibits several non-prostaglandin-related leucocyte functions, especially superoxide anion production. These serve as a basis for investigations which are reviewed showing the potential for the drug to prevent the pathological consequencies of myocardial ischaemia. The preparation of this book would not have been possible without the cooperation of the four companies who produce, market, or have research involvement with azapropazone, namely Siegfried AG (the manufacturers of the drug), A.H. Robins (U.K.) Co. Ltd., Robapharm AG (Switzerland) and E.!. duPont de Nemours (U.S.A., Switzerland and F.R.G.).
"synopsis" may belong to another edition of this title.
Language Notes:
Text: English, German
Introduction: French
Introduction: French
"About this title" may belong to another edition of this title.
- PublisherSpringer
- Publication date2011
- ISBN 10 9401068062
- ISBN 13 9789401068062
- BindingPaperback
- Number of pages256
- EditorRainsford K. D.
Buy New
Learn more about this copy
US$ 55.79
Shipping:
FREE
Within U.S.A.
Top Search Results from the AbeBooks Marketplace
Seller Image
Azapropazone: 20 years of clinical use [Paperback ]
Seller:
Rating
Book Description Soft Cover. Condition: new. Seller Inventory # 9789401068062
Buy New
US$ 55.79
Convert currency
Stock Image
Azapropazone: 20 years of clinical use
Published by
Springer
(2011)
ISBN 10: 9401068062
ISBN 13: 9789401068062
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Seller Inventory # ABLIING23Apr0412070056546
Buy New
US$ 59.29
Convert currency
Stock Image
Azapropazone : 20 years of clinical use
Published by
Springer
(2011)
ISBN 10: 9401068062
ISBN 13: 9789401068062
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9789401068062_lsuk
Buy New
US$ 65.22
Convert currency
Stock Image
Azapropazone: 20 Years of Clinical Use
Published by
Springer Netherlands
(2013)
ISBN 10: 9401068062
ISBN 13: 9789401068062
New
Paperback
Quantity: 2
Seller:
Rating
Book Description Paperback. Condition: Brand New. 1989 edition. 312 pages. 9.25x6.10x0.71 inches. In Stock. Seller Inventory # x-9401068062
Buy New
US$ 76.01
Convert currency
Seller Image
Azapropazone : 20 years of clinical use
Published by
Springer Netherlands
(2011)
ISBN 10: 9401068062
ISBN 13: 9789401068062
New
Taschenbuch
Quantity: 1
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Azapropazone is a chemically unique non-steroidal anti-inflammatory drug (benzotriazine oxide) which has found successful clinical applications in the therapy of a wide variety of arthritic conditions. This book summarizes the progress and critically reviews the clinical use and experimental studies since its introduction 20 years ago. Several studies focus on the physiochemical, pharmacological and toxico logical properties of this drug. The studies suggest that it has some unique properties compared with other non-steroidal anti-inflammatory drugs. Among these the novel observations are that azapropazone inhibits several non-prostaglandin-related leucocyte functions, especially superoxide anion production. These serve as a basis for investigations which are reviewed showing the potential for the drug to prevent the pathological consequencies of myocardial ischaemia. The preparation of this book would not have been possible without the cooperation of the four companies who produce, market, or have research involvement with azapropazone, namely Siegfried AG (the manufacturers of the drug), A.H. Robins (U.K.) Co. Ltd., Robapharm AG (Switzerland) and E.! duPont de Nemours (U.S.A., Switzerland and F.R.G.). Seller Inventory # 9789401068062
Buy New
US$ 65.24
Convert currency
Seller Image
Azapropazone
Published by
Springer Netherlands
(2011)
ISBN 10: 9401068062
ISBN 13: 9789401068062
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Section I Experimental.- 1 Introduction to therapy with azapropazone.- 2 The chemical classification of azapropazone.- 3 Survey of toxicological investigations of azapropazone.- 4 The mode of action of azapropazone in relation to its therapeutic actions in . Seller Inventory # 5833421
Buy New
US$ 53.02
Convert currency
Stock Image
Azapropazone : 20 years of clinical use
Seller:
Rating
Book Description PF. Condition: New. Seller Inventory # 6666-IUK-9789401068062
Buy New
US$ 91.79
Convert currency
Seller Image
Azapropazone
Published by
Springer Netherlands Sep 2011
(2011)
ISBN 10: 9401068062
ISBN 13: 9789401068062
New
Taschenbuch
Quantity: 2
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Azapropazone is a chemically unique non-steroidal anti-inflammatory drug (benzotriazine oxide) which has found successful clinical applications in the therapy of a wide variety of arthritic conditions. This book summarizes the progress and critically reviews the clinical use and experimental studies since its introduction 20 years ago. Several studies focus on the physiochemical, pharmacological and toxico logical properties of this drug. The studies suggest that it has some unique properties compared with other non-steroidal anti-inflammatory drugs. Among these the novel observations are that azapropazone inhibits several non-prostaglandin-related leucocyte functions, especially superoxide anion production. These serve as a basis for investigations which are reviewed showing the potential for the drug to prevent the pathological consequencies of myocardial ischaemia. The preparation of this book would not have been possible without the cooperation of the four companies who produce, market, or have research involvement with azapropazone, namely Siegfried AG (the manufacturers of the drug), A.H. Robins (U.K.) Co. Ltd., Robapharm AG (Switzerland) and E.! duPont de Nemours (U.S.A., Switzerland and F.R.G.). 312 pp. Englisch. Seller Inventory # 9789401068062
Buy New
US$ 93.79
Convert currency